| Stats | Twitter歴 4,416日（2009/04/14より） |
ツイート数 70,382（15.9件/日） |
表示するツイート :
Naoto T Ueno, MD, PhD@teamoncology
KEYNOTE-522 met the event-free survival difference by adding immunotherapy to newly diagnosed TNBC. You wonder if the difference is driven by PD-L1 positivity. I wonder when the details will come out. #BCSM
https://www.pmlive.com/pharma_news/new_trial_data_for_keytruda_in_triple-negative_breast_cancer_1370046…
posted at 02:03:15
Naoto T Ueno, MD, PhD@teamoncology
KEYNOTE-522 met the event-free survival difference by adding immunotherapy to newly diagnosed TNBC. No details. In March this year, the FDA did not approve the pembro. #bcsm
https://www.pmlive.com/pharma_news/new_trial_data_for_keytruda_in_triple-negative_breast_cancer_1370046…
posted at 02:02:16
Naoto T Ueno, MD, PhD@teamoncology
Just learned that @united mileage plus is 40 years. Congrats. Considering I flew Pan Am, the pacific route, bought by United. I am flying the same company for about 50 years. https://pic.twitter.com/Opza9b148j
posted at 00:08:19
Naoto T Ueno, MD, PhD@teamoncology
Cookies made by a patient with breast cancer! https://pic.twitter.com/wrHEQHitxC
posted at 06:01:24
Naoto T Ueno, MD, PhD@teamoncology
You can listen to my talk about targeting the cancer microenvironment in the context of inflammatory breast cancer for free until May 15th. https://hstalks.com/t/4286/targeting-the-cancer-microenvironment-inflammatory/?biosci…
posted at 06:10:12
Naoto T Ueno, MD, PhD@teamoncology
Vitamin D and calcium is generally recommended in all female for bone Heath reason. The question is whether you give more than the standard dose for metastatic breast cancer. I honestly do not have a clear answer. https://twitter.com/ibcnetworkuk/status/1388192222663880707…
posted at 03:53:08
Naoto T Ueno, MD, PhD@teamoncology
My patient, Janice. A lot to learn from her. Pacing yourself is very important for patients with metastatic inflammatory breast cancer. Pacing yourself by working with your healthcare team identifies the best treatment options with the highest QOL.
https://www.youtube.com/watch?v=fxdO-SFeU9g&t=87s…
posted at 02:59:31
Naoto T Ueno, MD, PhD@teamoncology
Yep, MBC is running a marathon. Janice Choe and I work together closely so that she can pace herself to find the best treatment options and maintain the best quality of life. https://twitter.com/mbcalliance/status/1385205749928890368…
posted at 02:52:37
Naoto T Ueno, MD, PhD@teamoncology
I enjoyed very much interacting with the IBC Patient Community. We talked about how to identify the best trials that will meet your need. Looking forward to having another session. Our @InflammatoryBCa program cares about communicating will the IBC community. https://twitter.com/TalkIBC/status/1388129908803702793…
posted at 02:14:57
Naoto T Ueno, MD, PhD@teamoncology
It is so true. I have asked these questions so many times. The data is legit but ----. Hahahahahaha. https://twitter.com/yochai_wolf/status/1387864390309924865…
posted at 09:09:01
Naoto T Ueno, MD, PhD@teamoncology
Common Breast Cancer Patients Question, ”Should I take any vitamins?" There are no specific vitamins that will help to fight breast cancer.
posted at 04:15:44
Naoto T Ueno, MD, PhD@teamoncology
Whole-genome sequencing of IBC! Collaboration between @MDAndersonNews @InflammatoryBCa and @YaleCancer. Germline changes of the TGF-beta pathway may contribute to the cause of IBC. https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-021-00879-x… #bcsm #oncoalert
posted at 00:10:06
Naoto T Ueno, MD, PhD@teamoncology
Presenting at TNBC Drug Development Digital Summit about the strategy development of immunomodulation to enhance immune checkpoint inhibitor based on our preclinical data. http://www.TNBC-summit.com #bcsm
posted at 03:13:11
Naoto T Ueno, MD, PhD@teamoncology
The vote was favorable to maintain the accerelated approval of atezolizumab for triple-negative metastatic breast cancer. Glad to hear this outcome. :) #bcsm
https://www.businesswire.com/news/home/20210427006185/en/FDA-Advisory-Committee-Votes-in-Favor-of-Maintaining-Accelerated-Approval-of-Genentech%E2%80%99s-Tecentriq-for-PD-L1-Positive-Metastatic-Triple-Negative-Breast-Cancer…
posted at 23:01:58
Naoto T Ueno, MD, PhD@teamoncology
Houston’s Methodist Hospital decides that any hosptial staff member who refuses to receive the new coronavirus vaccine by 6/7 will be terminated.
https://thehill.com/homenews/state-watch/550128-texas-hospital-first-to-require-all-employees-get-covid-19-vaccine…
posted at 02:19:56
Naoto T Ueno, MD, PhD@teamoncology
This year, we will have many new inflammatory breast cancer-specific clinical trials opening at @MDAndersonNews. We are excited about our capability to provide many options for the most aggressive breast cancer.
posted at 04:54:48
Naoto T Ueno, MD, PhD@teamoncology
Not quite sure how to react about this opinion. “I am not going to take the COVID-19 vaccine until the science can cure cancer.” I still recommend taking the vaccine unless there is a legit contradiction.
posted at 04:50:31
Naoto T Ueno, MD, PhD@teamoncology
A fascinating article about pros and cons of embracing emotional intelligence.
https://www.newyorker.com/magazine/2021/04/19/the-repressive-politics-of-emotional-intelligence…
posted at 04:51:38
Naoto T Ueno, MD, PhD@teamoncology
Systemic meta-analysis of preoperative standard chemotherapy in inflammatory breast cancer. #bcsm
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0250057…
posted at 04:50:36
Naoto T Ueno, MD, PhD@teamoncology
Appreciate the commentary on our article "Optimal Supportive Care for Patients With Metastatic Breast Cancer According to Their Disease Progression Phase."
Published at JCO Oncology Practice.
Paper → https://ascopubs.org/doi/full/10.1200/OP.20.00622?utm_source=JCO%2DOP%2DIn%2DThis%2DIssue%5F04132021%5FINTL&utm_medium=email&utm_term=2e11922a917da7b358e075c59033daa8…
Commentary → https://ascopubs.org/doi/full/10.1200/OP.20.01036?utm_source=JCO%2DOP%2DIn%2DThis%2DIssue%5F04132021%5FINTL&utm_medium=email&utm_term=2e11922a917da7b358e075c59033daa8… https://pic.twitter.com/HjxEOoMDxQ
posted at 20:55:22
Naoto T Ueno, MD, PhD@teamoncology
@antgiorda Thanks !! Hahaha
posted at 21:43:28
Naoto T Ueno, MD, PhD@teamoncology
Enjoy our quarterly newsletter (issue 23) about inflammatory breast cancer. You can get the latest update.
https://www.dropbox.com/s/7hhkh69rmzz61qv/Illuminating%20Hope%20-%20Issue%2023%20Apr%202021%20.pdf?dl=0…
posted at 21:43:09
Naoto T Ueno, MD, PhD@teamoncology
Why 'Messy' Leaders are the Future. I totally agree after going through the pandemic crisis. https://www.entrepreneur.com/article/368187
posted at 21:21:17
Naoto T Ueno, MD, PhD@teamoncology
Glad to know that you are doing well !! https://twitter.com/claremcory/status/1378040897842016261…
posted at 02:14:16
Naoto T Ueno, MD, PhD@teamoncology
A great website to confirm whether your E-mail address has been hacked. It is quite shocking to see the outcome. https://haveibeenpwned.com
posted at 02:13:21
Naoto T Ueno, MD, PhD@teamoncology
Today's pleasure reading! 🙂
Please enjoy reading about Dr. @Debeblab's journey as a scientist. The Scientist Magazine featured him very nicely.
Congrats!! We are very proud of you!!
https://www.the-scientist.com/scientist-to-watch/bisrat-debeb-models-how-cancer-spreads-to-the-brain-68575…
posted at 00:05:15
Naoto T Ueno, MD, PhD@teamoncology
Learning about neuroendocrine breast cancer from Dr. Yun Wu, @MDAndersonNews pathologist. Understanding the pathology is essential. They can be quite aggressive. Also, need to know where the original site of the neuroendocrine tumor. #bcsm
posted at 22:35:51
Naoto T Ueno, MD, PhD@teamoncology
Update of Systemic Treatment for Inflammatory Breast Cancer. The latest review. https://www.sciencedirect.com/science/article/pii/S2090123220302009?via%3Dihub… #bcsm
posted at 22:23:11
Naoto T Ueno, MD, PhD@teamoncology
We started the trend for a very active tweet for AACR ASCO SABCS!! Glad that we can push for the importance of social media in Oncology. https://twitter.com/mtmdphd/status/1374520838343458822…
posted at 18:15:41
Naoto T Ueno, MD, PhD@teamoncology
Dr Baselga passed away. A giant in breast medical oncology. Remember for his great clinical/translational science and his accurate career advice.
He passed away because of the CJD.
You can recognize him by donating to CJD related research Baselga Fund.
https://www.gofundme.com/f/dr-baselga-funds-for-creutzfeldtjakob-disease?fbclid=IwAR3sMGp13WRhYxz6z7R4Er2fZ6_i2O3SWICADcGm6-DiTw2C9yYzGYWGnq4…
posted at 18:13:20
Naoto T Ueno, MD, PhD@teamoncology
Not all tumors are equal. Excited that this paper got published. Thanks for the opportunity to collaborate. https://twitter.com/annals_oncology/status/1371819484797894669…
posted at 01:43:38
Naoto T Ueno, MD, PhD@teamoncology
FDA will review the data from 4/27 to 4/29 whether immunotherapy, atezolizumab + Abraxane should be eligible for continuous approval & additional trials are needed for metastatic TNBC. As you know, IMpassion 130 did not show the survival benefit. https://www.cancernetwork.com/view/leading-anticancer-immunotherapeutics-to-be-assessed-for-continued-use-for-indications-granted-accelerate-approval… #bcsm
posted at 03:57:49
Naoto T Ueno, MD, PhD@teamoncology
We plan to publish an inflammatory breast cancer management based on the virtual education session in Dec 2020.
https://cco.amegroups.com/post/view/inflammatory-breast-cancer-ongoing….
posted at 01:32:03
Naoto T Ueno, MD, PhD@teamoncology
Not quite sure how to evaluate these COVID-19 vaccines from China or Russia. Somebody educate me. https://twitter.com/medpagetoday/status/1366805535425769486…
posted at 02:55:35
Naoto T Ueno, MD, PhD@teamoncology
The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer https://dx.doi.org/10.1245/s10434-020-09392-8… #bcsm
posted at 02:37:08
Naoto T Ueno, MD, PhD@teamoncology
My perspective regarding this topic. Always this question comes up from my patients. So, what do you do? #bcsm
https://www.webmd.com/breast-cancer/features/breast-cancer-chronic-inflammation…
posted at 02:36:18
Naoto T Ueno, MD, PhD@teamoncology
@SuyogCancer @CancerNetwrk Agree. The company sure needs to provide more data.
posted at 02:32:27
Naoto T Ueno, MD, PhD@teamoncology
I am participating in the @NIH study section for two days. I love this Zoom review process b/c I do not have to travel & you can hear clearly what the reviewers say. The only problem is that there is no break, and you get tired to be on Zoom for close to 14-16 hrs every 4 M.
posted at 02:30:47
Naoto T Ueno, MD, PhD@teamoncology
FDA did not approve the Oral Paclitaxel and Encequidar in metastatic breast cancer. Concern regarding the toxicities & need an additional clinical trial. Not a surprise to me. Disappointment for the company and some investigators. #bcsm https://www.cancernetwork.com/view/fda-issues-response-letter-for-oral-paclitaxel-and-encequidar-in-metastatic-breast-cancer… via @CancerNetwrk
posted at 08:37:31
Naoto T Ueno, MD, PhD@teamoncology
A great article about the perspective of cancer treatment development. Wanted a bit more about the host impact on the treatment but I very much enjoyed reading the article. Well summarized.
https://cancerdiscovery.aacrjournals.org/content/early/2021/02/16/2159-8290.CD-20-1187…
posted at 22:53:28
Naoto T Ueno, MD, PhD@teamoncology
#racismisavirus, some of us have not learned the lesson from what happened to Japanese-American during WWII. What's happening now to #asianamerican is a continuation of bias leading to discrimination and hate. We all need to speak up and eradicate racism!
posted at 22:25:31
Naoto T Ueno, MD, PhD@teamoncology
Yep, it is correct. Japanese Mayo is a completely different one from what you get here in the US. I would definitely recommend getting a try.
https://www.salon.com/2021/02/28/why-chefs-are-reaching-for-japanese-mayo-and-you-should-be-too/…
posted at 22:19:18
Naoto T Ueno, MD, PhD@teamoncology
Very important. I agree to postpone breast cancer screening if you get the COVID-19 vaccine and if you can delay the screening. Talk with your doctor. Lymph node enlargement can happen with other vaccines.
https://www.knau.org/post/health-experts-recommend-postponing-mammograms-after-covid-19-vaccination…
posted at 01:50:00
Naoto T Ueno, MD, PhD@teamoncology
Work from home Pajama/Suit. How to deal with remote working, looking professional in a pajama. Do you need this?
上はビジネス、下はリラックス。リモートワーカー用部屋着をつくりました。お一ついかがでしょうか？
https://www.kickstarter.com/projects/197719879/wfh-jammies…
posted at 01:51:03
Naoto T Ueno, MD, PhD@teamoncology
Thank you to all the donors who supported the Inflammatory Breast Cancer Research through the @BootWalk. We have been very fortunate that we get tremendous support from our community. We have received these wonderfully decorated boots as a top fundraiser every year. https://pic.twitter.com/4upWz0j5tN
posted at 01:14:14
Naoto T Ueno, MD, PhD@teamoncology
Dad, why are you going to work? https://pic.twitter.com/TLHILqfsdD
posted at 00:35:42
Naoto T Ueno, MD, PhD@teamoncology
@dandjcline @BreastImaging @contessatexas My pleasure
posted at 11:25:48
Naoto T Ueno, MD, PhD@teamoncology
SBI @BreastImaging recommendation of the timing of mammogram and other imaging while or before receiving COVID-19 vaccination.
https://www.sbi-online.org/Portals/0/Position%20Statements/2021/SBI-recommendations-for-managing-axillary-adenopathy-post-COVID-vaccination.pdf…
posted at 06:53:21
Naoto T Ueno, MD, PhD@teamoncology
I have just learned this story. It gives me tear. The man-made disaster resulted in people who do not need to die.
If you want to support or honor them, here is the site → https://www.gofundme.com/f/ceo-nguyen
https://www.cnn.com/2021/02/21/us/sugar-land-texas-fire-deaths/index.html…
posted at 00:21:54
Naoto T Ueno, MD, PhD@teamoncology
Thank you for your willingness to help others. I used to need multiple transfusions. Now that I am cured, I would like to pay back but my history does not allow me to donate. :( https://twitter.com/CarlosHBarcenas/status/1363249047415488522…
posted at 01:52:28
